Investor Relations
SmallCapVoice.com
Stuart Smith
Ph: (512) 267-2430 SSmith@SmallCapVoice.com
OTCPK: AWTM
Authorized Shares:
100,000,000
Issued Outstanding:
58,942,684 as of Sep 6, 2007
Transfer Agent:
Pacific Stock Transfer Co
Advanced Wound Technologies Mid-Atlantic Hits CEOCorner at InvestSourceInc.com
AWT Signs Agreement with Medical Equipment Distribution Company
Christopher J. Neill
Founder/President/CEO
Ravi Saini Founder/President/Chairman
Donald Malter CFO/Treasurer/Secretary
Patrick R. Brown
Corporate Counsel
  |
Advanced Wound Technologies- |
AWT to Buy New Jersey Company
Advanced Wound Technologies-MidAtlantic, Inc. was founded to take advantage of the thriving Durable Medical Equipment market. The focus of the company is to secure marketing rights to patented medical technology, create treatment protocols using additional related products and market those protocols to healthcare providers as solutions to regulatory requirements or to increase efficiency and/or help the provider earn "Quality of Care" incentive bonuses from reimbursement sources.
Advanced Wound Technology's business, at present in the healthcare market is specializing in specific "incident rates" within the healthcare field. The targeted markets stand at approximately $235 Billion. Advanced Wound Technologies-MidAtlantic, Inc. distributes surfaces and associated equipment that can cure and prevent pressure sores in long-term care, acute care, and rehabilitation environments.
Why Invest in Advanced Wound Technologies-Mid Atlantic, Inc.?
- The Company was formed with a specific focus to take advantage of the flourishing durable medical equipment market domestically and internationally. In delivering the most state-of-the-art medical technologies at an affordable cost, we allow everyone access to the highest quality technologies, thus delivering equipment with greater therapeutic benefits.
- The MS 900T is the only system providing FIS Technology (Fluid Immersion Simulation). It is the only portable computerized bed system providing active feedback that allows the device to self-adjust to simulate the effects of neutral buoyancy (3 dimensional volumetric support).
- Our management team is comprised of highly accomplished individuals with substantial experience in building and financing companies across multiple industries. Each member of our team brings a specific skill set complimentary of one and all.
- We partner with both regional and local suppliers who share our commitment to excellence. These suppliers have the knowledge and expertise to deliver the quality products, superior service, and innovative solutions that will help us make a difference in the health care industry today. We can extend our supplier's capabilities beyond their traditional networks through an in-house financing division.
- A continuing project is creating treatment protocols around patented medical technology, and including additional related products and equipment to enhance and strengthen the treatment protocols. We will market these protocols to healthcare providers as solutions to regulatory requirements, to increase efficiency and to help the provider earn "Quality of Care" incentive bonuses from reimbursement sources.
- Working capital and acquisition financing is being obtained through two separate funding sources for a total contracted amount of $1,750,000. This funding will allow the Company to aggressively execute its 2007/2008 business strategy.
- International distribution in the Middle East is being handled through our wholly-owned subsidiary AWT, International. Newly appointed executives with 30 years of experience in business in the Middle East will run the division in Saudi Arabia. We have committed the first part of $150,000 in infrastructure expenditures budgeted, for the first year for the region.
- The Healthcare industry is highly fragmented with thousands of small, workable acquisition targets. We have spent many years analyzing our acquisition strategy and refining it to fit within the Healthcare industry. Our aggressive "Revenue Growth" strategy, as an overall growth plan, is ideal for the industry and what we see as necessary for the success of AWT.
- Part of our immediate focus is growth by acquisition.
- Wound care is the single fastest growing segment in healthcare today. Our focus on wound care, not solely decubitus ulcers, but all of wound care occurring because of pulmonary issues, diabetes, spinal cord injuries, burn victims, and surgical wounds, is a specific segment estimated at $235 billion world wide.
SmallCapVoice.com is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities members should buy or sell for themselves. Members should always check with their licensed financial advisor and their tax advisor to determine the suitability of any investment. This Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. Moreover this publication accepts compensation from some of the companies which it features. For compensation and complete disclaimer click here.